Detalhe da pesquisa
1.
Rational Combinations of PARP Inhibitors with HRD-Inducing Molecularly Targeted Agents.
Cancer Treat Res
; 186: 171-188, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978136
2.
Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 cases.
Mod Pathol
; 34(3): 613-626, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759977
3.
Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.
Gynecol Oncol
; 160(1): 322-332, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33160694
4.
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(7): 957-968, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32553118
5.
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
Gynecol Oncol
; 159(1): 72-78, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32771276
6.
Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Expert Opin Emerg Drugs
; 25(2): 165-188, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32569489
7.
Antibody-drug conjugates in gynecologic malignancies.
Gynecol Oncol
; 153(3): 694-702, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30929824
8.
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer.
Gynecol Oncol
; 153(3): 471-478, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30935717
9.
Strategies for Addressing Cancer Patients' Complaints of Fatigue.
Oncology (Williston Park)
; 31(11): 808-12, 2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29181836
10.
Endothelial TLR4 activation impairs intestinal microcirculatory perfusion in necrotizing enterocolitis via eNOS-NO-nitrite signaling.
Proc Natl Acad Sci U S A
; 110(23): 9451-6, 2013 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23650378
11.
Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib.
Clin Cancer Res
; 30(4): 687-694, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078898
12.
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer.
Gynecol Oncol Rep
; 52: 101348, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425459
13.
ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
J Natl Cancer Inst
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710487
14.
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.
JCO Precis Oncol
; 8: e2300635, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635934
15.
Perceived severity of childhood emotional, sexual, and physical abuse: Comparisons across psychologists, students, and the general public.
Psychol Trauma
; 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141026
16.
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.
J Clin Oncol
; 41(3): 599-608, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36174113
17.
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
Nat Med
; 29(6): 1400-1411, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277454
18.
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer.
JAMA Oncol
; 8(9): 1317-1322, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900726
19.
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer.
Nat Commun
; 12(1): 5574, 2021 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552099
20.
PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers.
Ther Adv Med Oncol
; 12: 1758835920944116, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32782491